News
Biorelate Ltd offers free access to AI drug discovery...
The company is granting researchers free use of cloud-based Galactic AI technology while the COVID-19 pandemic continues to impact labs worldwide.
Biorelate has announced it is...
Drug Research
Cobra signs supply agreement with AstraZeneca for manufacture of...
Cobra Biologics, part of the Cognate BioServices family, an international CDMO for biologics and pharmaceuticals, announced it has signed a supply agreement with AstraZeneca UK...
Drug Research
Neurocrine and Takeda Ink $2 Billion-Plus Neuroscience Development Deal
San Diego-based Neurocrine Biosciences is partnering with Japan’s Takeda Pharmaceutical to develop and commercialize molecules in Takeda’s early-to-mid-stage psychiatry pipeline. Takeda granted an exclusive license...
Clinical Trials
Eli Lilly Begins Phase III Study of RA Drug...
Eli Lilly will assess its JAK1/JAK2 inhibitor Olumiant (baricitinib) as a potential treatment for COVID-19 in a Phase III study.
Indianapolis-based Eli Lilly said the latest...
News
Corning Inc to expand Valor Glass production to accelerate...
Corning Inc. will receive $204 million in federal funding to expand manufacturing of its Corning Valor Glass packaging in order to expand production and aid...
News
Mobidiag Ltd Receives Second Tranche of €25M Financing from...
Mobidiag Ltd. announces that it has received the second tranche of €10M from the €25M growth capital loan signed with the European Investment Bank Group...
News
Dr. Reddys Laboratories enters into a Licensing Agreement with...
Dr. Reddy's Laboratories Ltd announced that it has entered into a non-exclusive Licensing Agreement with Gilead Sciences, Inc. (Gilead)that will grant Dr. Reddy’s the right...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.